Mahindra Manulife Equity Savings Fund
The Scheme seeks to generate long term capital appreciation and also income through investments in equity and equity related instruments, arbitrage opportunities and investments in debt and money market instruments.
Growthvine rating: 3/5 — ranked #10 of 24 in category.
Fund basics
| Category | Hybrid: Equity Savings |
|---|
| NAV | ₹21.95 (as of 2026-11-13) |
|---|
| AUM | ₹519 Cr |
|---|
| Expense ratio | 2.09% |
|---|
| Riskometer | Moderately High |
|---|
| Fund manager | Kush Sonigara |
|---|
| Exit load | For units in excess of 10% of the investment, 1% will be charged for redemption within 15 days |
|---|
Performance & risk
| 5-year annualised return | 6.17% |
|---|
| Sharpe ratio | 0.33 |
|---|
| Standard deviation | 5.56% |
|---|
| Max drawdown | −20.57% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 124.3% of NIFTY 50 Hybrid Short Duration Debt 25:75 Index's upside and 166.5% of its downside.
Market cap allocation
| Large cap | 83.0% |
|---|
| Mid cap | 5.7% |
|---|
| Small cap | 11.3% |
|---|
Concentration
| Top 5 holdings | 25.8% |
|---|
| Top 10 holdings | 36.4% |
|---|
| Total holdings | 80 |
|---|
Top holdings
- Net Receivable / Payable — 32.2%
- ICICI Bank Ltd. — 6.3%
- HDFC Bank Ltd. — 5.9%
- Reliance Industries Ltd — 5.3%
- Bajaj Finance Limited — 4.7%
- 7.79% Bajaj Housing Finance Limited 2031 — 4.2%
- Brookfield India Real Estate Trust — 3.8%
- 7.4% Bharti Telecom Limited 2029 — 3.8%
- Ambuja Cements Ltd. — 3.5%
- Sun Pharmaceutical Industries Ltd. — 3.3%
Top sectors
Not disclosed.
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 3.5% | Q2 | #8 of 24 |
| 2025 | 7.1% | Q2 | #8 of 21 |
| 2024 | 8.3% | Q4 (Bottom) | #17 of 21 |
| 2023 | 14.6% | Q2 | #7 of 20 |
| 2022 | 2.3% | Q3 | #13 of 18 |